What medication would you recommend in addition to Augmentin (amoxicillin/clavulanate) to treat a urinary tract infection with Proteus mirabilis and Enterococcus faecalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of UTI with Proteus mirabilis and Enterococcus faecalis

For a urinary tract infection with both Proteus mirabilis and Enterococcus faecalis, gentamicin should be added to Augmentin (amoxicillin/clavulanate) for optimal treatment, as it provides synergistic coverage against Enterococcus while Augmentin effectively treats the Proteus infection.

Rationale for Combination Therapy

  • Augmentin (amoxicillin/clavulanate) alone is effective against Proteus mirabilis but may benefit from additional coverage for Enterococcus faecalis in complicated or polymicrobial infections 1, 2
  • Gentamicin provides synergistic activity against Enterococcus faecalis when combined with beta-lactams like amoxicillin (contained in Augmentin) 1
  • This combination therapy approach is supported by guidelines for treating infections with these specific organisms, particularly when both are present simultaneously 1

Antimicrobial Selection Considerations

For Proteus mirabilis:

  • Proteus mirabilis in this case is susceptible to Augmentin, which is already part of the treatment plan 2, 3
  • Augmentin effectively treats amoxicillin-resistant strains of Proteus due to the beta-lactamase inhibitor (clavulanic acid) component 4
  • Recent evidence supports Augmentin's effectiveness against resistant Enterobacterales in urinary tract infections 5

For Enterococcus faecalis:

  • Enterococcus faecalis is susceptible to ampicillin (similar to amoxicillin in Augmentin) but benefits from synergistic therapy 1
  • Guidelines recommend the addition of an aminoglycoside (like gentamicin) to a beta-lactam for enhanced bactericidal activity against Enterococcus 1
  • Gentamicin at 3 mg/kg/day IV or IM in a single daily dose provides optimal synergy with the beta-lactam component of Augmentin 1

Dosing Recommendations

  • Augmentin: Continue at standard dosing (typically 875 mg PO twice daily) 1, 2
  • Add gentamicin: 3-5 mg/kg/day IV or IM as a single daily dose 1
  • Duration of therapy: 5-7 days for uncomplicated UTI; 10-14 days for complicated UTI 1

Important Clinical Considerations

  • Monitor renal function and gentamicin levels, particularly with extended therapy 1
  • Consider local resistance patterns when finalizing therapy choices 1
  • If gentamicin cannot be used due to contraindications, alternative options include:
    • Fluoroquinolones (if susceptible): Levofloxacin 500 mg daily or ciprofloxacin 500 mg twice daily 6, 7
    • For Enterococcus with high-level aminoglycoside resistance, consider alternative regimens such as ampicillin plus ceftriaxone 1

Common Pitfalls to Avoid

  • Treating only one organism in polymicrobial infections can lead to treatment failure 1
  • Underestimating the need for synergistic therapy against Enterococcus faecalis 1
  • Failing to monitor for aminoglycoside toxicity with prolonged therapy 1
  • Not adjusting therapy based on clinical response and susceptibility results 1

By adding gentamicin to Augmentin, you provide comprehensive coverage for both organisms with synergistic activity against Enterococcus faecalis while maintaining effective treatment for Proteus mirabilis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.